Hudson Valley Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.96M Sell
101,692
-48
-0% -$3.87K 0.97% 30
2026
Q1
$8.82M Sell
101,740
-669
-0.7% -$64.1K 1.14% 24
2025
Q4
$9.84M Sell
102,409
-200
-0.2% -$19.4K 1.09% 25
2025
Q3
$9.77M Sell
102,609
-45
-0% -$4.14K 1.02% 29
2025
Q2
$8.95M Sell
102,654
-419
-0.4% -$35.5K 0.98% 31
2025
Q1
$9.26M Sell
103,073
-352
-0.3% -$31.5K 1.11% 29
2024
Q4
$8.26M Sell
103,425
-912
-0.9% -$79K 0.94% 35
2024
Q3
$9.39M Sell
104,337
-1,779
-2% -$150K 1.04% 30
2024
Q2
$9.19M Buy
106,116
+923
+0.9% +$75.7K 1.19% 22
2024
Q1
$9.17M Sell
105,193
-923
-0.9% -$78.8K 1.1% 32
2023
Q4
$9.19M Sell
106,116
-5,372
-5% -$409K 1.26% 22
2023
Q3
$8.74M Sell
111,488
-793
-0.7% -$66.4K 1.23% 22
2023
Q2
$9.89M Sell
112,281
-588
-0.5% -$50.6K 1.34% 22
2023
Q1
$9.1M Sell
112,869
-2,825
-2% -$230K 1.27% 21
2022
Q4
$8.99M Sell
115,694
-3,130
-3% -$254K 1.36% 18
2022
Q3
$9.6M Sell
118,824
-3,360
-3% -$302K 1.54% 17
2022
Q2
$11M Sell
122,184
-6,395
-5% -$648K 1.71% 14
2022
Q1
$14.3M Sell
128,579
-3,642
-3% -$385K 1.92% 15
2021
Q4
$13.7M Sell
132,221
-902
-0.7% -$104K 2.14% 12
2021
Q3
$16.7M Buy
133,123
+717
+0.5% +$92.8K 2.86% 7
2021
Q2
$16.4M Buy
132,406
+643
+0.5% +$80.7K 2.86% 7
2021
Q1
$15.6M Buy
131,763
+2,126
+2% +$249K 2.78% 7
2020
Q4
$15.2M Buy
129,637
+208
+0.2% +$22.9K 2.9% 7
2020
Q3
$13.4M Sell
129,429
-12
-0% -$1.21K 2.9% 8
2020
Q2
$11.9M Sell
129,441
-605
-0.5% -$58K 2.76% 8
2020
Q1
$11.7M Sell
130,046
-17,611
-12% -$1.87M 3.25% 4
2019
Q4
$16.8M Sell
147,657
-369
-0.2% -$40.5K 3.57% 4
2019
Q3
$16.1M Sell
148,026
-460
-0.3% -$48K 3.73% 4
2019
Q2
$14.5M Sell
148,486
-414
-0.3% -$37.8K 3.35% 4
2019
Q1
$13.6M Sell
148,900
-6,117
-4% -$547K 3.29% 4
2018
Q4
$14.1M Buy
155,017
+5,415
+4% +$506K 3.25% 4
2018
Q3
$14.7M Buy
149,602
+672
+0.5% +$62.1K 3.41% 4
2018
Q2
$12.8M Sell
148,930
-2,215
-1% -$185K 3.13% 5
2018
Q1
$12.1M Sell
151,145
-4,973
-3% -$410K 3.06% 5
2017
Q4
$12.6M Sell
156,118
-6,518
-4% -$522K 3.12% 4
2017
Q3
$12.6M Sell
162,636
-1,835
-1% -$152K 3.28% 3
2017
Q2
$14.6M Sell
164,471
-215
-0.1% -$18.1K 4.02% 3
2017
Q1
$13.3M Sell
164,686
-12,555
-7% -$981K 3.7% 3
2016
Q4
$12.6M Buy
177,241
+6,166
+4% +$484K 3.72% 2
2016
Q3
$14.8M Buy
171,075
+263
+0.2% +$22.9K 4.59% 2
2016
Q2
$14.8M Sell
170,812
-13,581
-7% -$1.1M 4.75% 2
2016
Q1
$13.8M Sell
184,393
-46,745
-20% -$3.52M 4.49% 3
2015
Q4
$17.8M Sell
231,138
-7,495
-3% -$564K 5.54% 2
2015
Q3
$16M Sell
238,633
-525
-0.2% -$38.7K 5.18% 2
2015
Q2
$17.7M Buy
239,158
+36,002
+18% +$2.75M 5.53% 2
2015
Q1
$15.8M Buy
+203,156
New +$15.4M 5.36% 2
2013
Q3
Sell
-129,191
Closed -$6.65M 124
2013
Q2
$6.65M Buy
+129,191
New +$6.39M 3.18% 4

Other funds holding MDT

Hudson Valley Investment Advisors's MDT Position: Q2 2026 in Review

Hudson Valley Investment Advisors reduced its Medtronic (MDT) stake by 0.05% in Q2 2026, selling an estimated $3.87K and leaving 101,692 shares worth $7.96M. The position accounts for 0.97% of the portfolio, ranked #30.

Hudson Valley Investment Advisors first reported a position in MDT in Q2 2013 and has held it in 47 quarters since. The position peaked at $17.8M in Q4 2015. 959 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Hudson Valley Investment Advisors held 101,692 shares of Medtronic worth $7.96M as of Q2 2026.
  • Hudson Valley Investment Advisors sold 48 Medtronic shares in Q2 2026, an estimated $3.87K.
  • Medtronic made up 0.97% of Hudson Valley Investment Advisors's portfolio in Q2 2026, its #30 holding.
  • Hudson Valley Investment Advisors first reported a position in Medtronic in Q2 2013 and has held it in 47 quarters since.
  • Hudson Valley Investment Advisors's Medtronic position peaked at $17.8M in Q4 2015.
  • 959 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Hudson Valley Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.